Equity Analysis /
Thailand

Bangkok Expressway & Metro PCL: BUY on the dip

  • Omicron opens an opportunity

  • AstraZeneca to beat Omicron?

  • Impressive 2022-23 outlook

Kijapat Wongmetta
Kijapat Wongmetta

Equity Research Analyst

Bualuang Securities
3 December 2021